30 Mar

How APD Is Trading Compared to Its Peer


APD’s forward price-to-earnings

In the previous part of this series, we looked at analysts’ recommendations for Air Products & Chemicals (APD). In this part, we’ll compare APD’s valuation with its closest peer. As of March 29, 2017, APD was trading at a one-year forward PE (price-to-earnings) multiple of 21.2x. Its peer Praxair (PX) was trading at 20.3x.

How APD Is Trading Compared to Its Peer

Forward PE is a relative valuation method that considers a company’s future earnings for calculation. The forward PE ratio tells how much investors are paying for a stock per dollar of expected earnings in the next 12 months. It’s one of the most popular valuation tools that can help you compare two or more companies that operate in the same industry and see which stock is overvalued or undervalued.

APD is trading at a premium to its peer

Currently, Air Products & Chemicals is trading at a premium to its peer Praxair. In the past three years, APD and PX have both seen their revenues fall. APD’s revenue fell from $10.4 billion in fiscal 2014 to $9.5 billion in fiscal 2016. Its financial reporting period is from October 1 to September 30.

Praxair’s revenue has fallen more quickly, from $12.3 billion in 2014 to $10.5 billion in 2016. However, with the spin-off of Versum Materials (VSM), APD’s revenue is expected to be $7.8 billion in 2017. Some of its new business wins in the past four to five months are expected to push its revenue, along with expected executions from its backlog orders.

Analysts are expecting a higher net profit margin for APD, indicating a better operating efficiency than its peer. Analysts also expect APD’s EPS (earnings per share) to be $6.15. Investors are typically willing to pay a higher price for a company with a growth story in terms of margins and revenues.

You can indirectly hold APD by investing in the ProShares Ultra Basic Materials (UYM), which has 3.7% of its total portfolio in APD. The top holding of the fund is Dow Chemical (DOW), with a weight of 8.8% as of March 29, 2017.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.